Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trialsDevindee Nugawela, Kylie L Gorringe
6 September 2022
Retrograde hysterectomy approach in a patient with a frozen pelvis due to a suspected ovarian malignancyXuhui Dong, Lei Yuan, Liangqing Yao
28 September 2022
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial programRAINBO Research Consortium
20 December 2022
Quality management program in epithelial ovarian cancer: proposal in a Latin American countryDaniel Sanabria, Maria Camila Fernández, Natalia Hurtado, Adriana Ramos, Juliana Rodriguez
11 November 2022
Proportions and incidence of locally advanced cervical cancer: a global systematic literature reviewBradley J Monk, David S P Tan, José David Hernández Chagüi, Jitender Takyar, Michael J Paskow, Ana Tablante Nunes, Eric Pujade-Lauraine
14 October 2022
Oncological and reproductive outcomes for gonadotropin-releasing hormone agonist combined with aromatase inhibitors or levonorgestrel-releasing intra-uterine system in women with endometrial cancer or atypical endometrial hyperplasiaJunyu Chen, Dongyan Cao, Jiaxin Yang, Mei Yu, Huimei Zhou, Ninghai Cheng, Jinhui Wang, Ying Zhang, Peng Peng, Keng Shen
11 November 2022
Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancerMajke H.D. van Bommel, Johanna M.A. Pijnenborg, Louis J M van der Putten, Johan Bulten, Marc P.L.M. Snijders, Heidi V.N. Küsters-Vandevelde, Sanne Sweegers, M. Caroline Vos, Marjolein J.L. Ligtenberg, Astrid Eijkelenboom, Joanne A de Hullu, Casper Reijnen
16 November 2022
Drug repurposing as a potential source of innovative therapies in cervical cancerRica Capistrano I., Sonz Paul, Ingrid Boere, Pan Pantziarka, Supriya Chopra, Remi A Nout, Gauthier Bouche
22 September 2022
Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysisBrigida Anna Maiorano, Mauro Francesco Pio Maiorano, Domenica Lorusso, Massimo Di Maio, Evaristo Maiello
13 October 2022
Factors contributing to delays in initiation of front-line cervical cancer therapy: disparities in a diverse south Florida populationMolly Roy, Lindsey Finch, Deukwoo Kwon, Scott E Jordan, Sina Yadegarynia, Aaron Howard Wolfson, Brian Slomovitz, Lorraine Portelance, Marilyn Huang
5 October 2022